This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101132379. The JU receives support from the European Union’s Horizon Europe research and innovation programme, from The Leona M. and Harry B. Helmsley Charitable Trust, from Breakthrough T1D, from EFPIA, from COCIR, from Vaccines Europe, from EuropaBio and from MedTech. Additional funding is provided to associated UK partners through the UKRI (UK Research and Innovation) Guarantee Fund.
